Effects of dexamethasone combined with ropivacaine on labor analgesia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028693

Enrollment

Unknown

Registered

2019-12-31

Start date

2020-02-10

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetrics

Interventions

Group A:Dexamethasone combined with ropivacaine and sufentanil for epidural labor analgesia

Control group:ropivacaine and sufentanil for epidural labor analgesia

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Maternal voluntary participation in the study; 2. There was no contraindication of epidural anesthesia; 3. Have not participated in any clinical research before.

Exclusion criteria

Exclusion criteria: 1. Pregnancy with diabetes; 2. Fetal abnormality.

Design outcomes

Secondary

Measure	Time frame
Maternal comfort score;VAS score;Maternal fever rate;Duration of labor;Apgar score of 5 minutes;Cesarean section rate;Incidence of abnormal fetal heart rate monitoring;	—

Primary

Measure	Time frame
Total amount of ropivacaine and sufentanil;	—

Countries

China

Contacts

Public ContactDandan Zhou

Northwest Wommen's and Children's Hospital

zdd820326@163.com+86 17792303680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026